Hereditary Hemochromatosis
10 clinical trials · Condition
◉ Watch Hereditary Hemochromatosis
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers (NCT05238207) | Bond Biosciences | 2022-03-28 |
| PTG-300 in Subjects With Hereditary Hemochromatosis (NCT04202965) | Protagonist Therapeutics, Inc. | 2020-03-19 |
| Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH) (NCT03203850) | Novartis Pharmaceuticals | 2018-01-11 |
| Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients (NCT01398644) | Sanquin Research & Blood Bank Divisions | 2008-05-01 |
| Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis (NCT00395629) | Novartis Pharmaceuticals | 2006-08-01 |
| Cardiac Function in Patients With Hereditary Hemochromatosis (NCT00068159) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-12-08 |
Track Hereditary Hemochromatosis automatically
Every clearance here is in the API, with alerts when new ones post.